Tempus AI receives FDA clearance for pulmonary hypertension tool | MobiHealthNews
In July 2025, Tempus received FDA clearance for Tempus ECG-Low EF, software that uses AI to identify patients who may have a left ventricular ...
Read the original at MobiHealthNews ↗
- Topics
- Healthcare
- Mentions
- FDA
- Tracked via
- “that uses AI to”